| # | Drug | Count |
|---|---|---|
| 0 | AMBRISENTAN | 22 |
| 1 | MACITENTAN | 21 |
| 2 | TREPROSTINIL | 20 |
| 3 | SPIRONOLACTONE | 16 |
| 4 | FUROSEMIDE | 15 |
| 5 | SILDENAFIL CITRATE | 15 |
| 6 | TADALAFIL | 13 |
| 7 | EPOPROSTENOL | 10 |
| 8 | BOSENTAN | 9 |
| 9 | SILDENAFIL | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 10 | 0.0008 |
| 1 | SUCCINYLCHOLINE CHLORIDE | 1 | 0.0004 |
| 2 | SOFOSBUVIR | 7 | 0.0004 |
| 3 | IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA, | 1 | 0.0004 |
| 4 | SELEXIPAG | 8 | 0.0003 |
| 5 | MACITENTAN | 21 | 0.0003 |
| 6 | SILDENAFIL POWDER, | 7 | 0.0002 |
| 7 | BOSENTAN | 9 | 0.0002 |
| 8 | AMBRISENTAN | 22 | 0.0002 |
| 9 | TREPROSTINIL | 20 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacyclin Receptor Agonist [EPC] | 8 | 0.0003 |
| 1 | Prostacycline Vasodilator [EPC] | 29 | 0.0002 |
| 2 | Endothelin Receptor Antagonist [EPC] | 42 | 0.0002 |
| 3 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 7 | 0.0001 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 17 | 0.0001 |
| 5 | Aldosterone Antagonist [EPC] | 16 | 0.0001 |
| 6 | Nucleoside Analog Antiviral [EPC] | 8 | 0.0001 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 8 | Soluble Guanylate Cyclase Stimulator [EPC] | 3 | 0.0001 |
| 9 | Bile Acid [EPC] | 2 | 0.0001 |